UTI Asset Management Company Ltd

Q1 FY23 Earnings Call Analysis

Capital Markets

Full Stock Analysis
revenue: Category 3margin: Category 3orderbook: No informationfundraise: No informationcapex: Yes
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The provided pages from the document "1274795.pdf" do not contain specific information on the current or expected order book or pending orders. The discussions primarily focus on: - Fund performance, sales strategy, and market share in equity and hybrid funds. - Dividend payout ratios and their maintenance or increase. - Expense outlook including staff cost growth. - Digital strategy and branch expansion plans. - Competitive dynamics in distributor commissions and product positioning. - Fund inflows, yields, and distributions across channels. - Launch of new products, including Balanced Advantage Fund (BAF) awaiting regulatory approval. - International business expense considerations related to UTI International. No explicit details on order book, pending orders, or similar order-related metrics are mentioned in these excerpts.
💰

fundraise

Any current/future new fundraising through debt or equity?

- UTI Capital Pvt. Ltd. is building its business and managing several active debt funds with current fundraisings: - UTI Structured Debt Opportunities Fund (SDOF) III launched in September 2022, currently in fundraising and investing stage with AUM Rs. 300 crore. - For UTI International, there are plans for new fund launches in the U.S. market; legal and registration expenses are expected but precise costs are not finalized. - No direct equity New Fund Offers (NFOs) launched in FY23, but several ETFs and fund of funds were introduced. - Approval for launching a Balanced Advantage Fund (BAF) is awaited from SEBI, which is strategized to aid future fundraising. - The company is focusing on expanding geographical reach and digital presence to support product sales and fund inflows. Thus, active new fundraising is ongoing primarily through debt-focused products at UTI Capital and planned product launches internationally and in hybrid categories post regulatory approval.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Opening 29 new branch offices across India in FY 2023-24, with an estimated investment of around Rs. 3.2 crore; branches expected to break even in 1.5 to 2 years. (Page 16-17) - Investments in digital strategy: expanding a 14-member digital team, hiring data analysts, and upgrading digital and IT assets to enhance investor engagement via apps and websites. (Page 18) - Significant investments in building capabilities and infrastructure for investment teams, including customized training and development programs. (Page 4) - UTI Capital is building alternative investment products with plans to launch funds such as Real Estate Opportunities Fund; has made net loss of Rs. 3.3 crore due to investments to build this business. (Page 5, 9) - UTI International expanding operations with new subsidiary UTI Investments America for North American market; incurring legal and registration expenses for new fund launches. (Page 21, 9) - Past significant investments in IT infrastructure and security, with reduced IT investments expected going forward. (Page 23)
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Focus on improving fund performance to drive inflows and market share, especially in equity funds. - Strategic launch of a BAF product pending SEBI approval to boost fundraising. - Continuous engagement with distributors, including banking channels, to promote products. - Expansion plans include opening 29 new branches targeting Tier 3 and Tier 4 cities with a break-even expected in 1.5-2 years. - Digital strategy enhancement with hiring of data analysts and improving digital platforms to engage young investors. - Staff cost expected to grow moderately (~3.5%) due to controlled salary increases and retirements. - Payout ratio increased from 48% to 63% in FY22, expected to be maintained or improved, subject to board decisions. - Expectation to stabilize or improve yields with a focus on new AUM and managing competitive dynamics. - Overall aim to regain and grow market share through performance, distribution expansion, and digital initiatives.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Staff costs expected to grow moderately (~3.5%) due to controlled salary hikes and retirements, aiding cost management (Page 23, 22). - Non-staff costs to have limited increase; one-time expenses (e.g., sales meet) removed, but CSR and renovation costs may add (Page 23). - Focus on cost optimization is expected to keep administrative expenses stable without significant rise (Page 23). - Overall expense growth targeted to improve beyond past 6% rate through initiatives and cost discipline (Page 23). - Income growth supported by increased payout ratio (raised from 48% in FY21 to 63% in FY22), expected to be maintained or improved (Page 26). - Business expansion, including digital and physical branches, aims for medium-term profitability improvements (branches expected to break-even in 1.5-2 years) (Page 17,16). - Stable equity yields anticipated with a largely new AUM book, contributing to stabilized operating earnings (Page 15).